Methylphenidate Immediate-Release Tablets Shortage

• • Ritalin immediate release tablet, Sandoz, 10 mg, bottle, 100 count, NDC 00078-0440-05
  • Ritalin immediate release tablet, Sandoz, 20 mg, bottle, 100 count, NDC 00078-0441-05
  • Ritalin immediate release tablet, Sandoz, 5 mg, bottle, 100 count, NDC 00078-0439-05
  • Methylphenidate Hydrochloride immediate release tablet, Accord, 10 mg, bottle, 100 count, NDC 16729-0479-01
  • Methylphenidate Hydrochloride immediate release tablet, Accord, 10 mg, bottle, 100 count, NDC 16729-0480-01
  • Methylphenidate Hydrochloride immediate release tablet, Accord, 5 mg, bottle, 100 count, NDC 16729-0478-01
  • Methylphenidate Hydrochloride immediate release tablet, Camber, 10 mg, bottle, 100 count, NDC 31722-0174-01 - discontinued
  • Methylphenidate Hydrochloride immediate release tablet, Camber, 20 mg, bottle, 100 count, NDC 31722-0175-01 - discontinued
  • Methylphenidate Hydrochloride immediate release tablet, Camber, 5 mg, bottle, 100 count, NDC 31722-0173-01 - discontinued
  • Methylphenidate Hydrochloride immediate release tablet, KVK-Tech, 10 mg, bottle, 100 count, NDC 10702-0101-01
  • Methylphenidate Hydrochloride immediate release tablet, KVK-Tech, 20 mg, bottle, 100 count, NDC 10702-0102-01
  • Methylphenidate Hydrochloride immediate release tablet, KVK-Tech, 5 mg, bottle, 100 count, NDC 10702-0100-01
  • Methylphenidate Hydrochloride immediate release tablet, Solco Healthcare US, 10 mg, bottle, 100 count, NDC 43547-0487-10
  • Methylphenidate Hydrochloride immediate release tablet, Solco Healthcare US, 20 mg, bottle, 100 count, NDC 43547-0488-10
  • Methylphenidate Hydrochloride immediate release tablet, Solco Healthcare US, 5 mg, bottle, 100 count, NDC 43547-0486-10
  • Methylphenidate Hydrochloride immediate release tablet, Sun Pharma, 20 mg, bottle, 100 count, NDC 57664-0230-88

• • Accord states the reason for the shortage is active ingredient delay.
  • Amneal has all marketed presentations available.
  • Camber discontinued methylphenidate immediate-release tablets.
  • KVK-Tech has methylphenidate immediate-release tablets on allocation due to meeting DEA quota.
  • Mallinckrodt refuses to provide availability information.
  • Novartis divested Ritalin tablets to Sandoz.
  • Sandoz did not provide a reason for the shortage.
  • Solco did not provide a reason for the shortage.
  • Sun Pharma has methylphenidate immediate-release tablets on shortage due to regulatory issues.
  • XLCare states the reason for the shortage is active ingredient delay.

• • Methylphenidate Hydrochloride immediate release tablet, Amneal, 10 mg, bottle, 100 count, NDC 00115-1801-01
  • Methylphenidate Hydrochloride immediate release tablet, Amneal, 20 mg, bottle, 100 count, NDC 00115-1802-01
  • Methylphenidate Hydrochloride immediate release tablet, Amneal, 5 mg, bottle, 100 count, NDC 00115-1800-01
  • Methylphenidate Hydrochloride immediate release tablet, Sun Pharma, 10 mg, bottle, 100 count, NDC 57664-0229-88
  • Methylphenidate Hydrochloride immediate release tablet, Sun Pharma, 5 mg, bottle, 100 count, NDC 57664-0228-88

Estimated Resupply Dates

• • Accord has all presentations on back order and the company cannot estimate a release date.
  • KVK-Tech has all presentations on allocation.
  • Sandoz has Ritalin 5 mg and 20 mg tablets on allocation. Ritalin 10 mg tablets are on back order and the company cannot estimate a release date.
  • Solco has all presentations on allocation.
  • Sun Pharma has 20 mg tablets on back order and the company estimates a release date of early- to mid-June 2024.